News from cangene corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 21, 2014, 11:20 ET Cangene Announces Completion of Acquisition by Emergent BioSolutions

TSX: CNJ Readers are referred to the cautionary note regarding Forward-looking Information at the end of this release. Unless noted otherwise, all dollar amounts are in U.S. dollars. WINNIPEG, Feb....


Feb 18, 2014, 17:37 ET Cangene Receives Court Approval of Plan of Arrangement for Acquisition by Emergent BioSolutions

/Readers are referred to the cautionary note regarding Forward-looking Information at the end of this release. Unless noted otherwise, all dollar amounts are in U.S. dollars. / TSX: CNJ WINNIPEG, Feb....


Feb 13, 2014, 08:00 ET Cangene Shareholders Approve Acquisition by Emergent BioSolutions

Readers are referred to the cautionary note regarding Forward-looking Information at the end of this release. Unless noted otherwise, all dollar amounts are in U.S. dollars. TSX: CNJ WINNIPEG, Feb....


Jan 28, 2014, 07:00 ET Cangene announces expiration of the Hart-Scott-Rodino waiting period for acquisition by Emergent BioSolutions Inc.

Readers are referred to the cautionary note regarding Forward-looking Information at the end of this release. Unless noted otherwise, all dollar amounts are in U.S. dollars. WINNIPEG, Jan. 28, 2014...


Dec 13, 2013, 17:40 ET Cangene Reports First Quarter 2014 Results and Election of Directors

Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are in U.S....


Dec 11, 2013, 18:39 ET Cangene To Be Acquired By Emergent BioSolutions For US$222 Million

Cangene Shareholders to Receive US$3.24 Per Share (C$3.44 Per Share) in Cash Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the...


Oct 29, 2013, 21:46 ET Cangene Reports Fiscal 2013 Results; Net Income Up $29.6 million from Prior Year

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are...


Sep 19, 2013, 10:04 ET Cangene Awarded Biodefence Contract for Anthrax Immune Globulin (AIGIV) by the U.S. Government

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are...


Sep 11, 2013, 18:46 ET Cangene receives marketing authorization approval for WinRho 1500 LQ in Portugal

TSX: CNJ Readers are referred to the cautionary note regarding Forward-looking Information. WINNIPEG, Sept. 11, 2013 /CNW/ - Cangene Corporation (Cangene) announced today that the company's wholly...


Sep 03, 2013, 07:06 ET Cangene Announces Extension of VIGIV Biodefence Contract with U.S. Government

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are...


Jul 29, 2013, 18:55 ET FDA lifts clinical hold on Cangene's hemophilia compound IB1001

TSX: CNJ Readers are referred to the cautionary note regarding Forward-looking Information at the end of this release. WINNIPEG, July 29, 2013 /CNW/ - Cangene Corporation (Cangene) today announces...


Jun 13, 2013, 18:08 ET Cangene Announces Withdrawal of Marketing Authorization Application for Investigational Hemophilia Compound IB1001 in Europe

Intends to Re-File with Additional Clinical Data Readers are referred to the cautionary notes regarding Forward-looking Information at the end of this release. TSX: CNJ WINNIPEG, June 13, 2013 /CNW/...


Jun 05, 2013, 18:33 ET Cangene Reports Third Quarter 2013 Results

Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are in U.S....


Mar 25, 2013, 07:36 ET Cangene announces FDA approval of Botulism Antitoxin

Licensure of BATTM is Key Milestone in Highly Successful Collaboration with BARDA to Ensure U.S. Preparedness Against Potential Botulism-Related Public Health Risks Readers are referred to the...


Mar 13, 2013, 19:19 ET Cangene Reports Second Quarter 2013 Results

Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are in U.S....


Feb 21, 2013, 19:04 ET Cangene Advances Alzheimer's Disease Research with Technology Developed at the University of British Columbia

Readers are referred to the cautionary notes regarding Forward-Looking Information at the end of this release. TSX: CNJ WINNIPEG & VANCOUVER, Feb. 21, 2013 /CNW/ - A truly made-in-Canada treatment...


Feb 20, 2013, 01:30 ET Cangene announces closing of acquisition of late stage hemophilia B product

Readers are referred to the cautionary notes regarding Forward-Looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are in U.S....


Feb 12, 2013, 20:25 ET FDA Advisory Committee Votes in Favour of Cangene's Botulism Antitoxin Product

Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are in U.S....


Feb 06, 2013, 06:30 ET Cangene announces agreement to acquire late stage hemophilia B product

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are...


Jan 08, 2013, 18:16 ET U.S. Food and Drug Administration approves Cangene's VARIZIG®

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-Looking Information at the end of this release. WINNIPEG, AB, Jan. 8, 2013 /CNW/ - Cangene Corporation ("Cangene") today...


Dec 12, 2012, 19:23 ET Cangene Reports First Quarter 2013 Results; Earnings of 7 Cents Per Share

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are...


Oct 24, 2012, 22:50 ET Cangene Reports Fiscal 2012 Results

TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release. Unless noted otherwise, all dollar amounts are...


Sep 17, 2012, 06:00 ET Cangene Announces Agreement to Sell U.S. Plasma Centres

Transaction Supports Refocused Specialty Biopharmaceutical Strategy TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information at the end of this release. WINNIPEG,...


Aug 28, 2012, 06:00 ET Cangene announces continuation of biodefence programs with U.S. Government

Contracts leverage core biodefence competencies and supplement commercial product business TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS...


Aug 07, 2012, 06:00 ET Cangene appoints Michael Adelman Vice President of Commercial Operations

Focuses on building commercial business TSX: CNJ Readers are referred to the cautionary notes regarding Forward-looking Information at the end of this release. WINNIPEG, Aug. 7, 2012 /CNW/ - Cangene...